EU regulators approve plasma device from Cytomedix

12/12/2012 | MassDevice.com (Boston)

Cytomedix has earned CE mark approval in Europe for use of its Angel concentrated platelet-rich plasma technology with bone marrow aspirate. The system, which was cleared by the FDA last month, includes adjustable settings to allow customized processing and preparation of plasma in clinical settings or at the point of care.

View Full Article in:

MassDevice.com (Boston)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Associate Director, Regulatory Affairs - Promotional Review
Novo Nordisk
Princeton, NJ